---
title: "Xizang Weixinkang Pharmaceutical: Received government subsidies related to revenue amounting to 34.3437 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246663013.md"
description: "On the evening of June 30, Xizang Weixinkang Pharmaceutical announced that on March 27 and June 30, the company and its wholly-owned subsidiary, Xizang Zhongwei Chengkang Pharmaceutical Co., Ltd., received a total of 34.3437 million yuan in corporate development funds for 2024. This government subsidy is related to revenue and accounts for 13.95% of the company's net profit for the 2024 fiscal year"
datetime: "2025-06-30T11:38:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246663013.md)
  - [en](https://longbridge.com/en/news/246663013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246663013.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical: Received government subsidies related to revenue amounting to 34.3437 million yuan

On the evening of June 30, Xizang Weixinkang Pharmaceutical announced that on March 27 and June 30, the company and its wholly-owned subsidiary, Xizang Zhongwei Chengkang Pharmaceutical Co., Ltd., received a total of 34.3437 million yuan in enterprise development funds for 2024. This government subsidy is related to revenue and accounts for 13.95% of the company's net profit for the 2024 fiscal year

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [MINSHENG BANK  Interim Net Profit Falls 8.6% YoY to RMB19.537 billion; Declares Interim Dividend of RMB1.18 per 10 Shares](https://longbridge.com/en/news/297426428.md)
- [Unigold says Dominican community backs ESIA launch for Neita gold project](https://longbridge.com/en/news/297646851.md)
- [Geiger Makes New Uranium Discovery at the Previously Undrilled Fox Zone, Directly on Trend with Orano's Kiggavik Uranium Deposits | BSENF Stock News](https://longbridge.com/en/news/297633664.md)
- [TKMS says F127 air-defense frigate design advances after customer-driven development work](https://longbridge.com/en/news/297673767.md)
- [06:05 ETKarmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer](https://longbridge.com/en/news/297497971.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**